ODYY ODYSSEY GROUP INTL INC
- 0.051000
- +0.021000+70.00%
ODYSSEY GROUP INTL INC News
Odyssey Health, Inc. Strengthens Balance Sheet With $8.7 Million in Net Equity
LAS VEGAS, NV / ACCESSWIRE / March 27, 2024 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., (the "Company") a company focused on developing unique, life-enhancing medi
Oragenics Completes Acquisition of Odyssey Health's Neurological Assets
Oragenics, Inc. (NYSE American: OGEN) announces it has completed its previously announced acquisition of assets related to Odyssey Health, Inc.'s (OTCQB: ODYY) ("Odyssey") proprietary neurological drug therapies and technologies.
Odyssey Health Gains Shareholder Approval for Asset Sale With Oragenics
Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
LAS VEGAS, NV / ACCESSWIRE / November 16, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, ha
Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders
LAS VEGAS, NV / ACCESSWIRE / November 15, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), formerly Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,
Odyssey Health, Inc. Provides Update on Asset Purchase Agreement With Oragenics, Inc.
LAS VEGAS, NV / ACCESSWIRE / October 18, 2023 / Odyssey Health, Inc. (OTCQB:ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products is p
Oragenics to Acquire Certain Assets of Odyssey Health
Oragenics: Odyssey to Retain Other Assets, Operations >OGEN ODYY
Oragenics: Odyssey to Retain Other Assets, Operations >OGEN ODYY
Oragenics to Pay $1 Million Cash, 8 Million Series F Convertible Preferred Shares >OGEN
Oragenics to Pay $1 Million Cash, 8 Million Series F Convertible Preferred Shares >OGEN
Oragenics To Acquire Odyssey Health's Neurological Drug Technology Pipeline Including Concussion Drug Candidate >OGEN ODYY
Oragenics To Acquire Odyssey Health's Neurological Drug Technology Pipeline Including Concussion Drug Candidate >OGEN ODYY
Odyssey Health Inc. Begins Trading on the OTCQB
LAS VEGAS, NV / ACCESSWIRE / October 4, 2023 / Odyssey Health, Inc. (formerly known as Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), is a medical device and pharmaceutic
Odyssey Health to Develop Intranasal Nerve Agent Antidote
Odyssey Health Completes Phase I Human Clinical Trial for Concussion Drug, Preparing for Phase II
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
Las Vegas, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical product
Odyssey Health, Inc. Schedules Annual Meeting of Stockholders
Las Vegas, Nevada, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on d
Odyssey Health, Inc. Makes Statement Regarding Its Concussion Drug Development Program
Las Vegas Nevada, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., (the "Company" "Odyssey") a company focused on developing a unique dru
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II
Las Vegas, NV, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products,
Odyssey Health, Inc. Launches New Corporate Website
Odyssey Health, Inc. Launches New Corporate Website $ODYY - Odyssey Health, Inc. - New Corporate WebsiteLas Vegas, NV, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odys
Brett Favre Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
ORLANDO, FL / ACCESSWIRE / July 14, 2022 / RedChip Companies will air a new interview with Odyssey Health, Inc. (OTC Pink:ODYY), f/k/a Odyssey Group International, Inc., on The RedChip Money Report® o
Us WTI crude closed up 0.2 per cent on Monday and hit an intraday high since 2014.
In the early morning of the 19th Beijing time, US WTI crude oil futures closed slightly higher on Monday, setting the highest intraday price level since 2014. Phil Flynn, a senior market analyst at The Price Futures Group, said the high price of crude oil futures increased the possibility of undermining demand in the energy market. West Texas Intermediate (WTI) for November delivery rose 16 cents, or 0.2%, to $82.44 a barrel on the New York Mercantile Exchange. At one point today, the futures price rose to $83.87, the highest intraday price since 2014.
Analysis
Price Target
No Data
